✦ LIBER ✦

Evolving strategies for prostate cancer chemoprevention trials

✍ Scribed by Ronald Lieberman

Book ID: 106032779
Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 178 KB
Volume: 21
Category: Article
ISSN: 0724-4983
DOI: 10.1007/s00345-003-0317-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Strategies for chemoprevention of prosta

Strategies for chemoprevention of prostate cancer

✍ Kelloff, G J; Lieberman, R; Brawer, M K; Crawford, E D; Labrie, F; Miller, G J; 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB

Chemoprevention of prostate cancer: The

Chemoprevention of prostate cancer: The prostate cancer prevention trial

✍ Thompson, Ian M.; Coltman, Charles A.; Crowley, John 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

## BACKGROUND. A variety of innovative approaches to the prevention of prostate cancer are now available, including selenium, alpha tocopherol, dietary interventions, and vitamin D. Perhaps the most promising opportunity is based upon considerable evidence that cumulative androgen exposure of the

Chemoprevention for prostate cancer

✍ Michael K. Brawer; William J. Ellis 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB

Chemoprevention of prostate cancer: Guid

Chemoprevention of prostate cancer: Guidelines for possible intervention strategies

✍ E. David Crawford; William R. Fair; Gary J. Kelloff; Michael M. Lieber; Gary J. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

The "natural history" of prostate cancer may bedevil the development of guidelines for chemoprevention interventions. Can strategies be designed to direct agents to those lesions which have the potential to develop localized extension that may become symptomatic or metastatic disease? Of necessity o

Strategies for phase II cancer chemoprev

Strategies for phase II cancer chemoprevention trials: Cervix, endometrium, and ovary

✍ Dr. Gary J. Kelloff; Charles W. Boone; James A. Crowell; Susan G. Nayfield; Erne 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 782 KB

Well-designed and conducted Phase 11 clinical trials are very important to cancer chemoprevention drug development. Three critical aspects govern the design and conduct of these trials-wellcharacterized agents, suitable cohorts, and reliable biomarkers for measuring efficacy that can serve as surrog

Chemoprevention strategies for prostate

Chemoprevention strategies for prostate cancer: The role of 5α-reductase inhibitors

✍ Glenn J. Gormley 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB

Prostate cancer is a major health problem for the aging male population. Despite hormonal dependence, the inevitable emergence of androgen insensitive tumors, which have a dismal prognosis, highlights the need to develop prevention strategies such as chernoprevention. An acceptable agent must interf